MMP9 and neoplasm: Consistent with these findings, PRL-3 is known to enhance tumor aggressiveness through regulation of matrix metalloproteinases, particularly via overexpression of angiogenin and invasion-associated enzymes of the MMP9-TIMP1/2 axis.29